Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder

American Psychiatric Association, 2000. Diagnostic and statistical manual of mental disorders (4th ed, text rev). Barnes, 1989, A rating scale for drug-induced akathisia, Br. J. Psychiatry, 154, 672, 10.1192/bjp.154.5.672 Bowden, 2010, Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial, J. Clin. Psychiatry, 71, 130, 10.4088/JCP.09m05482yel Chapel, 2016, Lurasidone dose response in bipolar depression: a population dose-response analysis, Clin. Ther., 38, 4, 10.1016/j.clinthera.2015.11.013 Citrome, 2012, Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study, Int. Clin. Psychopharmacol., 27, 165, 10.1097/YIC.0b013e32835281ef Citrome, 2013, Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study, CNS Spectr., 1 Endicott, 1993, Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure, Psychopharmacol. Bull., 29, 321 Gitlin, 1995, Relapse and impairment in bipolar disorder, Am. J. Psychiatry, 152, 1635, 10.1176/ajp.152.11.1635 Goodwin, 2016, Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology, J. Psychopharmacol., 30, 495, 10.1177/0269881116636545 Grunze, 2013, WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder, World J. Biol. Psychiatry, 14, 154, 10.3109/15622975.2013.770551 Guy W., 1976. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, and Welfare publication (ADM) 76-338 Rockville, MD: National Institute of Mental Health; 1976. Health Canada product monograph: 〈http://www.sunovion.ca/monographs/latuda.pdf〉. (Accessed on 20 May 2017). IsHak, 2012, Health-related quality of life in bipolar disorder, Bipolar Disord., 14, 6, 10.1111/j.1399-5618.2011.00969.x Joffe, 2004, A prospective, longitudinal study of percentage of time spent ill in patients with bipolar I or bipolar II disorders, Bipolar Disord., 6, 62, 10.1046/j.1399-5618.2003.00091.x Judd, 2002, The long-term natural history of the weekly symptomatic status of bipolar I disorder, Arch. Gen. Psychiatry, 59, 530, 10.1001/archpsyc.59.6.530 Judd, 2005, Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study, Arch. Gen. Psychiatry, 62, 1322, 10.1001/archpsyc.62.12.1322 Ketter, 2016, Lurasidone in the long-term treatment of patients with bipolar disorder: a 24-week open-label extension study, Depress. Anxiety., 33, 424, 10.1002/da.22479 Latuda US prescribing information: 〈http://www.latuda.com/LatudaPrescribingInformation.pdf〉. (Accessed on 20 May 2017). Loebel, 2013, Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: a 12-month, double-blind, noninferiority study, Schizophr. Res., 147, 95, 10.1016/j.schres.2013.03.013 Loebel, 2013, Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizoprenia: a ramdomized, double-blind, placedo- and active-controlled trial, Schizophr. Res, 145, 101, 10.1016/j.schres.2013.01.009 Loebel, 2014, Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study, Am. J. Psychiatry, 171, 160, 10.1176/appi.ajp.2013.13070984 Loebel, 2014, Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study, Am. J. Psychiatry, 171, 169, 10.1176/appi.ajp.2013.13070985 Lurasidone US Prescribing Information, 2014. 〈http://www.latuda.com/LatudaPrescribingInformation.pdf〉. (Accessed on 13 February 2016). Macfadden, 2009, A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently, Bipolar Disord., 11, 827, 10.1111/j.1399-5618.2009.00761.x Marcus, 2011, Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study, Bipolar Disord., 13, 133, 10.1111/j.1399-5618.2011.00898.x Montgomery, 1979, A new depression scale designed to be sensitive to change, Br. J. Psychiatry, 132, 382, 10.1192/bjp.134.4.382 National Collaborating Centre for Mental Health, 2014. Bipolar Disorder: The Assessment and Management of Bipolar Disorder in Adults, Children and Young People in Primary and Secondary Care. Leicester UK: The British Psychological Society; The Royal College of Psychiatrists. Ostacher, 2016, Florida best practice psychotherapeutic medication guidelines for adults with bipolar disorder: a novel, practical, patient-centered guide for clinicians, J. Clin. Psychiatry, 77, 920, 10.4088/JCP.15cs09841 Pacchiarotti, 2015, Hyperprolactinemia and medications for bipolar disorder: systematic review of a neglected issue in clinical practice, Eur. Neuropsychopharmacol., 25, 1045, 10.1016/j.euroneuro.2015.04.007 Perlis, 2006, Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), Am. J. Psychiatry, 163, 217, 10.1176/appi.ajp.163.2.217 Popovich, 2012, Polarity index of pharmacologic agents used for maintenance treatment of bipolar disorder, Eur. Neuropsychopharmacol., 22, 339, 10.1016/j.euroneuro.2011.09.008 Posner, 2011, The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults, Am. J. Psychiatry, 168, 1266, 10.1176/appi.ajp.2011.10111704 Quiroz, 2010, Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder, Biol. Psychiatry, 68, 156, 10.1016/j.biopsych.2010.01.015 Rush, 2003, The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression, Biol. Psychiatry., 54, 573, 10.1016/S0006-3223(02)01866-8 Sheehan, 1983 Simpson, 1970, A rating scale for extrapyramidal side effects, Acta. Psychiatr. Scand. Suppl., 212, 11, 10.1111/j.1600-0447.1970.tb02066.x Suppes, 2009, Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (trial 127), Am. J. Psychiatry, 166, 476, 10.1176/appi.ajp.2008.08020189 Tohen, 2003, The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence, Am. J. Psychiatry, 160, 2099, 10.1176/appi.ajp.160.12.2099 Tohen, 2004, Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone, Br. J. Psychiatry, 184, 337, 10.1192/bjp.184.4.337 Vázquez, 2015, Recurrence rates in bipolar disorder: systematic comparison of long-term prospective, naturalistic studies versus randomized controlled trials, Eur. Neuropsychopharmacol., 25, 1501, 10.1016/j.euroneuro.2015.07.013 Vieta, 2008, Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126), J. Affect. Disord., 109, 251, 10.1016/j.jad.2008.06.001 Vieta, 2010, Treatment options for bipolar depression: a systematic review of randomized, controlled trials, J. Clin. Psychopharmacol., 30, 579, 10.1097/JCP.0b013e3181f15849 Vieta, 2008, A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone, World J. Biol. Psychiatry, 9, 219, 10.1080/15622970701530917 Weisler, 2011, Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study), J Clin. Psychiatry, 72, 1452, 10.4088/JCP.11m06878 Young, 2011, A rating scale for mania: reliability, validity and sensitivity, Br. J. Psychiatry, 133, 429, 10.1192/bjp.133.5.429